• Discounts and special offers
  • Subscriber-only articles and interviews
  • Breaking news and trending topics

Already a subscriber?

By signing up, you accept Moneywise's Terms of Use, Subscription Agreement, and Privacy Policy.

Not interested ?

GSK

GSK plc (GSK) is arguably undervalued. The stock currently has a forward price-to-earnings ratio of 9.91. It also offers a dividend yield of 3.5%.

The underlying business is in a transition. Activist hedge fund Elliott Management took a position in the company in 2021, pushing for changes to unlock value. In 2022, the company spun off its consumer health-care division into a new independent firm called Haleon. The spinoff was said to be financially beneficial for GSK. "One of the perks for GSK of the demerger was also a £7bn dividend which helped to reduce net debt of £19.8bn at the end of 2021," reported the Financial Times.

The company has been focused on its core pharmaceuticals and vaccine products. This seems to be delivering growth. In 2023, GSK raised its guidance for the year twice. It expects revenue to be as much as 13% higher and adjusted earnings per share to be as much as 20% higher than the previous year.

Strong sales and a low valuation should put this megacorporation on your radar of undervalued stocks.

How to get a free $10 to invest in your future

An app called Acorns automatically rounds up purchases made on your credit or debit card to the nearest dollar and places the excess "change" into a smart investment portfolio. You get $10 immediately from your first investment.

Get $10

Alphabet

Google’s parent company Alphabet (GOOGL) is in the midst of an interesting battle. Rivals have deployed billions into large language models and artificial intelligence that some say could erode Google’s dominance in the search market.

“[Google is] the 800-pound gorilla in this [market] … I want people to know that we made them dance,” Microsoft (MSFT) CEO Satya Nadella told The Verge shortly after OpenAI released ChatGPT.

Meanwhile, Jeff Bezos has bet on another AI startup, Perplexity AI, that’s also trying to capture some of this lucrative market.

For now, Google retains its crown as the king of search engines. The platform holds 91.61% market share, as of December 2023, according to data from StatCounter. Google is also actively competing in the AI race with its ChatGPT rival Bard, which is being gradually integrated across the company’s portfolio of apps.

These initiatives could help the company sustain its growth momentum. In the third quarter of 2023, the firm reported 11% growth in revenue and 41.5% growth in net income year-over-year. The stock trades at a forward price-to-earnings ratio of 22.22, which isn’t cheap but could be justified by this robust growth rate.

This fair-valued stock should certainly be on your watchlist for 2024 as the AI race heats up.

Trade your favorite stocks any time

Investing doesn't have to be hard. Robinhood is the only place you can trade stocks, options and ETFs 24 hours a day, 5 days a week, all still commission-free. Start building your portfolio with as little as $1.

Get Started
Vishesh Raisinghani Freelance Writer

Vishesh Raisinghani is a freelance contributor at MoneyWise. He has been writing about financial markets and economics since 2014 - having covered family offices, private equity, real estate, cryptocurrencies, and tech stocks over that period. His work has appeared in Seeking Alpha, Motley Fool Canada, Motley Fool UK, Mergers & Acquisitions, National Post, Financial Post, and Yahoo Canada.

Disclaimer

The content provided on Moneywise is information to help users become financially literate. It is neither tax nor legal advice, is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. Tax, investment and all other decisions should be made, as appropriate, only with guidance from a qualified professional. We make no representation or warranty of any kind, either express or implied, with respect to the data provided, the timeliness thereof, the results to be obtained by the use thereof or any other matter.